These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 29946793)
1. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793 [TBL] [Abstract][Full Text] [Related]
2. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392 [TBL] [Abstract][Full Text] [Related]
3. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet. Lee MR; Park KI; Ma JY Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum. Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169 [TBL] [Abstract][Full Text] [Related]
5. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366 [TBL] [Abstract][Full Text] [Related]
6. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway. Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892 [TBL] [Abstract][Full Text] [Related]
7. Tyrosol Attenuates High Fat Diet-Induced Hepatic Oxidative Stress: Potential Involvement of Cystathionine β-Synthase and Cystathionine γ-Lyase. Sarna LK; Sid V; Wang P; Siow YL; House JD; O K Lipids; 2016 May; 51(5):583-90. PubMed ID: 26518313 [TBL] [Abstract][Full Text] [Related]
9. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437 [TBL] [Abstract][Full Text] [Related]
10. Hesperetin ameliorates hepatic oxidative stress and inflammation Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953 [TBL] [Abstract][Full Text] [Related]
11. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis. Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323 [TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503 [TBL] [Abstract][Full Text] [Related]
14. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation. Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075 [TBL] [Abstract][Full Text] [Related]
15. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state. Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454 [TBL] [Abstract][Full Text] [Related]
16. α-Lactalbumin Peptide Asp-Gln-Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids-Treated HepG2 Cells and High-Fat Diet-Induced NAFLD Mice by Activating the PPARα Pathway. Chen H; Ma Y; Qi X; Tian J; Ma Y; Niu T Mol Nutr Food Res; 2023 Aug; 67(16):e2200499. PubMed ID: 37354055 [TBL] [Abstract][Full Text] [Related]
17. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress. Jiang Y; Chen L; Wang H; Narisi B; Chen B J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885 [TBL] [Abstract][Full Text] [Related]